It is currently Thu Sep 18, 2014 6:54 pm

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.

MSRV Retrovirus, phase 2

Hello everybody :smile:

I am involved in the following study, described hereafter.

Mister Hervé Perron, who found the retrovirus, gave more details here : (in French), and you can follow my experience regarding this test here : (in French).

Source :

Spun out in 2006 from ...
Read more : MSRV Retrovirus, phase 2 | Views : 4601 | Replies : 27


Not sure if this has been posted elsewhere. ... ture=share
Read more : Phenytoin | Views : 885 | Replies : 0

BG 12

Hey Dig, long time. What is your latest take on BG12? Is this really fumeric acid? All my Neuros seem to think its the Holy Grail but if we can just do it ourselves why would anyone sign on for a high dollar Med? Rituxan coming up hard and fast!
Read more : BG 12 | Views : 1669 | Replies : 8

Wow-too good to be true? Nanotechnology- Immune therapy ... 111312.php

I guess this is just getting picked up by national media.

Looks like phase 2 is only recruiting newly diagnosed:

"A phase 2 trial will explore how effective the therapy is in newly diagnosed patients, and will expand the sample size for further evaluation."

trisca wrote:
And if it is a real breakthrough and solves it, how long before all the studies are done and we ...
Read more : Wow-too good to be true? Nanotechnology- Immune therapy | Views : 1520 | Replies : 1

Nuron closing in on new treatment for relapsing MS


Nuron Biotech Inc. said Tuesday it has completed enrollment of 500 patients for a pivotal phase-III study evaluating the safety and effectiveness of the company’s experimental multiple sclerosis treatment.

Phase-III studies are typically the last hurdle a drug developer must clear before seeking approval for a new drug candidate.

Nuron, an Exton, Pa., specialty biologics and vaccines company, is developing NU100 to treat relapsing remitting multiple sclerosis.

Shankar Musunuri, the company’s founder and CEO, ...
Read more : Nuron closing in on new treatment for relapsing MS | Views : 1008 | Replies : 1

MIS 416 - Phase 2 interim results


Innate Immunotherapeutics today announced positive interim data from the company’s Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS). Results of the open-label, dose-escalation/confirmation trial showed MIS416 to be well tolerated and identified a clinical dose for further evaluation. Moreover, during the dose confirmation portion of the study, 8 of 10 patients with secondary progressive MS who were treated with MIS416 for 12 weeks showed ...
Read more : MIS 416 - Phase 2 interim results | Views : 1346 | Replies : 0

DEATH Tysabri Patient

A young Pole (29 J) Tysabri patient has died today + + + + +
Read more : DEATH Tysabri Patient | Views : 1370 | Replies : 0


HI friends my name is seeva an d found a news about a single pill could treat alzheimer's , parkinsons's and m.s and strokes has bean unveiled by scinentists ... rosis.html please reffer to the website for more details. the drugs known as MW151 &MW189 have patented by US scintist at Northwestern university Chicago.if you check in the for the two ...
Read more : RE NEW DRUG TO TREAT M.S UNDER WAY | Views : 1330 | Replies : 0

Stanford study sounds promising

This study just came out this week and is on the main Stanford University website page. Sounds like a glimmer of hope for a new MS drug possibly in the future.

"Researchers discover reviled substance involved in Alzheimer's can reverse paralysis in mice with multiple sclerosis"
Read more : Stanford study sounds promising | Views : 1245 | Replies : 0


Login  •  Register


Total posts 220016 • Total topics 22748 • Total members 14352

Contact us | Terms of Service